Dexcom (DXCM) is raising fiscal year 2026 guidance for Non-GAAP Operating Margin and Adjusted EBITDA Margin: Non-GAAP Gross Profit Margin of approximately 63-64%; Non-GAAP Operating Margin of approximately 23-23.5%; Adjusted EBITDA Margin of approximately 31-31.5%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: